BAMBEC

This brand name is authorized in Austria, Brazil, Germany, Spain, Singapore, United Kingdom

Active ingredients

The drug BAMBEC contains one active pharmaceutical ingredient (API):

1 Bambuterol UNII 786Q84QZ3F - BAMBUTEROL HYDROCHLORIDE

Bambuterol is an active precursor of the selective β2-adrenergic agonist terbutaline. Bambuterol is the bis-N,N-dimethyl-carbamate of terbutaline. Bambuterol is a remarkably selective and potent inhibitor of cholinesterase. Bambuterol is indicated for the management of asthma, bronchospasm and/or reversible airways obstruction. Read about Bambuterol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BAMBEC Tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R03CC12	Bambuterol	R Respiratory system → R03 Drugs for obstructive airway diseases → R03C Adrenergics for systemic use → R03CC Selective beta-2-adrenoreceptor agonists
Discover more medicines within R03CC12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 502300601131310
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00256751, 00256768, 00256774, 04424530, 07379008
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 59896
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 142079, 355778
Country: SG	Health Sciences Authority	Identifier(s): 09269P